DoctorAdam

1. 3. The FAQ identifies Olympia Pharmaceuticals and Carie Boyd Pharmaceuticals as network partners without assigning this specific formulation to either. It describes clinician review of submitted answers, with video or live chat in some states. Its explicit 44-state service list differs from its separate 47-states-plus-DC statement; the enumerated list is retained without inventing coverage for omitted states. https://doctoradam.com/pages/faq
2. 4. The actual product advertises a starting $199 and describes consultation, prescription, medication and shipping in one monthly price. This does not establish the selected dose, exact first payment or renewal total. https://doctoradam.com/pages/tirzepatide-oral-tablet
3. 5. The product says no membership and includes evaluation, while the generic terms describe a recurring monthly membership, a separate diagnostic visit, separately paid Quest lab work and excess-service charges of $15 per consultation/lab interpretation or $125 per at-home draw. Applicability to this treatment is unresolved; none of these conditional fees is assumed universal or zero. https://doctoradam.com/pages/tirzepatide-oral-tablet https://doctoradam.com/pages/terms-and-conditions
4. 6. The current product identifies unqualified tirzepatide and the stated delivery form without establishing brand or compounded formulation. The earlier compounded category was more specific than the current source supports. This is a record-classification correction for the same observed program, not proof that the medication formulation changed. https://doctoradam.com/pages/tirzepatide-oral-tablet
5. 7. The actual product advertises a starting $129 and describes consultation, prescription, medication and shipping in one monthly price. This does not establish the selected dose, exact first payment or renewal total. https://doctoradam.com/pages/semaglutide
6. 8. The product says no membership and includes evaluation, while the generic terms describe a recurring monthly membership, a separate diagnostic visit, separately paid Quest lab work and excess-service charges of $15 per consultation/lab interpretation or $125 per at-home draw. Applicability to this treatment is unresolved; none of these conditional fees is assumed universal or zero. https://doctoradam.com/pages/semaglutide https://doctoradam.com/pages/terms-and-conditions
7. 9. The actual product advertises a starting $229 and describes consultation, prescription, medication and shipping in one monthly price. This does not establish the selected dose, exact first payment or renewal total. https://doctoradam.com/products/glp1-tirzepatide-injection
8. 10. The product says no membership and includes evaluation, while the generic terms describe a recurring monthly membership, a separate diagnostic visit, separately paid Quest lab work and excess-service charges of $15 per consultation/lab interpretation or $125 per at-home draw. Applicability to this treatment is unresolved; none of these conditional fees is assumed universal or zero. https://doctoradam.com/products/glp1-tirzepatide-injection https://doctoradam.com/pages/terms-and-conditions
9. 11. The current product identifies unqualified tirzepatide and the stated delivery form without establishing brand or compounded formulation. The earlier compounded category was more specific than the current source supports. This is a record-classification correction for the same observed program, not proof that the medication formulation changed. https://doctoradam.com/products/glp1-tirzepatide-injection
10. 12. The injection ingredient list also names niacinamide (vitamin B3). No vial or pen is established by the actual administration text. https://doctoradam.com/products/glp1-tirzepatide-injection
11. 13. The actual product advertises a starting $129 and describes consultation, prescription, medication and shipping in one monthly price. This does not establish the selected dose, exact first payment or renewal total. https://doctoradam.com/pages/semaglutide-drops
12. 14. The product says no membership and includes evaluation, while the generic terms describe a recurring monthly membership, a separate diagnostic visit, separately paid Quest lab work and excess-service charges of $15 per consultation/lab interpretation or $125 per at-home draw. Applicability to this treatment is unresolved; none of these conditional fees is assumed universal or zero. https://doctoradam.com/pages/semaglutide-drops https://doctoradam.com/pages/terms-and-conditions
13. 15. The current product identifies unqualified semaglutide and the stated delivery form without establishing brand or compounded formulation. The earlier compounded category was more specific than the current source supports. This is a record-classification correction for the same observed program, not proof that the medication formulation changed. https://doctoradam.com/pages/semaglutide-drops

September 2026

1. 16. Same FAQ page contains two contradictory state-coverage claims: one sentence says 'serving patients in 47 states and Washington, D.C., excluding NJ, MS, and AK,' while a separate, explicitly-enumerated 'We proudly serve the following states' list two lines later names only 44 states (also missing MA, RI, and VT). Recorded the explicit enumerated list per the register's rule to prefer a real list over a vague count, and flagged the contradiction here rather than reconciling it. No 'oral tirzepatide' category exists in this register's schema, so the Tirzepatide Oral Tablets product was recorded as compounded tirzepatide / oral-tablet. Cancellation was recorded as not found because the only relevant policy language found describes non-cancellable, non-refundable shipped orders, with no statement that an ongoing subscription itself can be canceled going forward.